These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32053003)

  • 1. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
    Xu L; Ge X; Sun N; Liu X
    Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
    Sun NN; Ge XL; Liu XS; Xu LL
    Radiol Med; 2020 Feb; 125(2):165-176. PubMed ID: 31605354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-tumour histogram analysis of pharmacokinetic parameters from dynamic contrast-enhanced MRI in resectable oesophageal squamous cell carcinoma can predict T-stage and regional lymph node metastasis.
    Chen YL; Li R; Chen TW; Ou J; Zhang XM; Chen F; Wu L; Jiang Y; Laws M; Shah K; Joseph B; Hu J
    Eur J Radiol; 2019 Mar; 112():112-120. PubMed ID: 30777199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy.
    Kozumi M; Ota H; Yamamoto T; Umezawa R; Matsushita H; Ishikawa Y; Takahashi N; Matsuura T; Takase K; Jingu K
    Eur Radiol; 2018 Oct; 28(10):4296-4305. PubMed ID: 29725833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.
    Shukla-Dave A; Lee NY; Jansen JF; Thaler HT; Stambuk HE; Fury MG; Patel SG; Moreira AL; Sherman E; Karimi S; Wang Y; Kraus D; Shah JP; Pfister DG; Koutcher JA
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1837-44. PubMed ID: 21601373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.
    Sun NN; Liu C; Ge XL; Wang J
    Diagn Interv Radiol; 2018 Jul; 24(4):195-202. PubMed ID: 30091709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of K
    Wang D; Liu S; Fu J; Zhang P; Zheng S; Qiu B; Liu H; Ye Y; Guo J; Zhou Y; Jiang H; Yin S; He H; Xie C; Liu H
    J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38910009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced magnetic resonance imaging: A novel approach to assessing treatment in locally advanced esophageal cancer patients.
    Gu L; Xie X; Guo Z; Shen W; Qian P; Jiang N; Fan Y
    Niger J Clin Pract; 2021 Dec; 24(12):1800-1807. PubMed ID: 34889788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2-IIA2 cervical cancers.
    Zhang A; Song J; Ma Z; Chen T
    Radiol Med; 2020 Dec; 125(12):1233-1242. PubMed ID: 32424659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.
    Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
    Radiother Oncol; 2013 Apr; 107(1):117-22. PubMed ID: 23333024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI.
    Zheng D; Chen Y; Liu X; Chen Y; Xu L; Ren W; Chen W; Chan Q
    J Magn Reson Imaging; 2015 Jun; 41(6):1528-40. PubMed ID: 25136770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Textural features based enhanced contrast CT images predicts prognosis to concurrent chemoradiotherapy in stage III esophageal squamous cell cancer.
    Xie Y; Wang Q; Cao B; Lv J; Wang Y; Wu L; Dong M; Li T
    Cancer Biomark; 2020; 27(3):325-333. PubMed ID: 31903981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting tumor responses and patient survival in chemoradiotherapy-treated patients with non-small-cell lung cancer using dynamic contrast-enhanced integrated magnetic resonance-positron-emission tomography.
    Huang YS; Chen JL; Chen JY; Lee YF; Huang JY; Kuo SH; Yen RF; Chang YC
    Strahlenther Onkol; 2019 Aug; 195(8):707-718. PubMed ID: 30610356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
    Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
    Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy.
    Zhao Z; Zhang Y; Wang X; Geng X; Zhu L; Li M
    Cancer Med; 2020 Aug; 9(16):5881-5888. PubMed ID: 32627960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.
    Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e485-92. PubMed ID: 22014954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging.
    Lei J; Han Q; Zhu S; Shi D; Dou S; Su Z; Xu X
    Oncol Lett; 2015 Dec; 10(6):3607-3612. PubMed ID: 26788177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?
    Palmisano A; Esposito A; Rancoita PMV; Di Chiara A; Passoni P; Slim N; Campolongo M; Albarello L; Fiorino C; Rosati R; Del Maschio A; De Cobelli F
    Clin Radiol; 2018 Oct; 73(10):911.e1-911.e7. PubMed ID: 30029837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
    Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
    Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.